Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Virus Res ; 339: 199285, 2024 01 02.
Artigo em Inglês | MEDLINE | ID: mdl-38013142

RESUMO

OBJECTIVES: This study aimed to explore the impact of oxidative stress and extracellular matrix integrity on rotavirus infection in various cancer cells, including breast cancer, acute lymphoblastic leukemia, and melanoma. METHODS: We induced oxidative stress using ROS-inducing drugs (cisplatin, metronidazole, melatonin, valproic acid, doxorubicin, losartan, nitrofurantoin, and DHA) and investigated the effects on viral infection in MCF-7, Reh, A375, B16-F1, and SK-MEL-28 cells and the generation of virions from infected cells by harvesting the supernatants every two hours, reinfecting other cells, and analyzing cell viability and DNA fragmentation. FINDINGS: In MCF-7 and Reh cells, rotavirus Wt1-5 infection led to increased ROS generation, virion production, membrane permeability, mitochondrial dysfunction, DNA damage, and cell death. These effects were amplified by ROS-inducing drugs. Conversely, melanoma cells (SK-MEL-28 and A375) with a robust extracellular matrix network showed limited sensitivity to the drugs. Notably, losartan, which modulates the extracellular matrix, enhanced viral infection in melanoma cells (99 %). CONCLUSIONS: Oxidative stress promotes oncolytic rotavirus infection in breast cancer and acute lymphoblastic leukemia cells, suggesting potential utility in combination with radiotherapy or chemotherapy due to their shared induction of intracellular oxidative stress.


Assuntos
Neoplasias da Mama , Melanoma , Leucemia-Linfoma Linfoblástico de Células Precursoras , Infecções por Rotavirus , Rotavirus , Humanos , Feminino , Melanoma/terapia , Rotavirus/genética , Rotavirus/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Losartan/farmacologia , Losartan/uso terapêutico , Linhagem Celular Tumoral , Apoptose , Estresse Oxidativo , Leucemia-Linfoma Linfoblástico de Células Precursoras/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...